Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
ESHO 2023
Programm
Poster
Personen
Suche
EN
Zurück
Poster session
Poster session 1
Clinical applications & Trial
Termin
Datum:
27.09.2023
Zeit:
17:30
–
18:30
Ort / Stream:
Poster 2
Programm
tba
P10
Proof of concept study combining Whole-Body hyperthermia with Gemcitabine and Oxaliplatin (GEMOX) in pancreatic cancer patients
John-Paul Bogers (Mechelen, BE)
Clinical Applications & Trials
P11
Role of localized hyperthermia therapy in neoadjuvant chemotherapy for patients with Lymph-Node-Positive Triple-Negative breast cancer: A report from a single institution experience
Dr. Kwang Kuk Park (Busan, KR)
Clinical Applications & Trials
P12
Case study of the treatment outcome in a patient with recurrent intrahepatic cholangiocarcinoma using regional deep hyperthermia
Dr. Kwang Kuk Park (Busan, KR)
Clinical Applications & Trials
P13
Palliative treatment containing modulated electro hyperthermia alone or combined with chemotherapy versus second and third lines of chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative study on 217 patients
Prof Giammaria Fiorentini (Pesaro, IT)
Clinical Applications & Trials
P14
Hyperthermia in the treatment of high-risk soft tissue sarcomas: A systematic review
Paraskevi Danai Veltsista (Berlin, DE)
Clinical Applications & Trials
P15
Multimodal treatment for soft tissue sarcomas of trunk and limbs: radiotherapy and chemotherapy in combination with radiative hyperthermia
Dr. Pasquale Trecca (Rome, IT)
Clinical Applications & Trials
P16
Hyperthermia with short-course-Radiotherapy in TNT for LARC: Initial outcomes and toxicity
Dr Barbara Salas (Las Palmas, ES)
Clinical Applications & Trials
P17
The real world experience in setting up the first superficial hyperthermia service using wIRA in the UK and a proposal of a prospective pilot study (ThermoRad) to assess the effectiveness and safety profile of adding superficial hyperthermia to palliative radiotherapy in locally advanced or recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) or cutaneous squamous cell carcinoma (cSCC) not suitable for radical treatment
Dr. Anthony Kong (London, GB)
Clinical Applications & Trials
P18
Prospective clinical investigation of modulated electro hyperthermia as an adjunct to neoadjuvant chemotherapy in breast cancer patients: Enhancing efficacy and objective assessment
Dr. A. Marcell Szasz (Budapest, HU)
Hyperthermia Drug Delivery, Nanoparticles
P19
Functional Hyperthermia plan in Catalan Institute of Oncology (ICO)
Marina Arangüena Peñacoba (Barcelona, ES)
Other
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz